BIOMAT Database Logo BIOMAT Database Logo

[Significance of detecting minimal residual disease in multiple myeloma]. 2015

Jian Hou, and Jianling Fan
Email: houjian@medmail.com.cn.

UI MeSH Term Description Entries
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018365 Neoplasm, Residual Remnant of a tumor or cancer after primary, potentially curative therapy. Minimal Residual Disease,Residual Cancer,Residual Tumor,Minimal Disease, Residual,Residual Disease, Minimal,Residual Neoplasm,Residual Tumour,Cancer, Residual,Minimal Residual Diseases,Residual Cancers,Residual Minimal Disease,Residual Minimal Diseases,Residual Neoplasms,Residual Tumors,Residual Tumours,Tumour, Residual

Related Publications

Jian Hou, and Jianling Fan
Circulating Tumour DNA for Detecting Minimal Residual Disease in Multiple Myeloma.
January 2018, Seminars in hematology,
Jian Hou, and Jianling Fan
Multiple Myeloma Minimal Residual Disease.
January 2016, Cancer treatment and research,
Jian Hou, and Jianling Fan
Minimal residual disease in multiple myeloma.
July 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Jian Hou, and Jianling Fan
Minimal residual disease monitoring in multiple myeloma.
March 2002, Best practice & research. Clinical haematology,
Jian Hou, and Jianling Fan
Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease.
January 2018, Seminars in hematology,
Jian Hou, and Jianling Fan
Standardisation of minimal residual disease in multiple myeloma.
November 2017, European journal of cancer care,
Jian Hou, and Jianling Fan
[Clinical Significance and Detection Techniques of Minimal Residual Disease in Multiple Myeloma-Review].
June 2017, Zhongguo shi yan xue ye xue za zhi,
Jian Hou, and Jianling Fan
Multiple myeloma, immunotherapy and minimal residual disease.
January 2016, Neoplasma,
Jian Hou, and Jianling Fan
Minimal residual disease in multiple myeloma: current status.
October 2021, Biomarker research,
Jian Hou, and Jianling Fan
Controversies in the assessment of minimal residual disease in multiple myeloma: clinical significance of minimal residual disease negativity using highly sensitive techniques.
December 2014, Current hematologic malignancy reports,
Copied contents to your clipboard!